Detalhe da pesquisa
1.
Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial.
Acta Med Philipp
; 58(6): 7-13, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846161